Sonic Healthcare Ltd. Sponsored ADR (SKHHY)
(Delayed Data from OTC)
$14.52 USD
-0.38 (-2.54%)
Updated Sep 18, 2025 10:02 AM ET
3-Hold of 5 3
B Value C Growth A Momentum B VGM
Fundamental Charts
About Price to Cash Flow
The Price to Cash Flow ratio or P/CF is price divided by its cash flow per share. It's another great way to determine whether a company is undervalued or overvalued with the denominator being cash flow. One of the reasons why some investors prefer the P/CF ratio over the P/E ratio is because the net income of the cash flow portion rightly adds depreciation and amortization back in since these are not cash expenditures. In contrast, the net income that goes into the earnings portion of the P/E ratio does not add these in, thus artificially reducing the income and skewing the P/E ratio. Like the P/E ratio, a lower number is considered better. A value under 20 is generally considered good.
SKHHY 14.52 -0.38(-2.54%)
Will SKHHY be a Portfolio Killer in September?
Zacks Investment Research is releasing its prediction for SKHHY based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for SKHHY
All You Need to Know About Sonic Healthcare Ltd. Sponsored ADR (SKHHY) Rating Upgrade to Buy
SKHHY: What are Zacks experts saying now?
Zacks Private Portfolio Services
Other News for SKHHY
Wilsons Reaffirms Their Buy Rating on Sonic Healthcare Limited (SHL)
Sonic Healthcare’s Earnings Call Highlights Growth and Challenges
Wilsons Keeps Their Buy Rating on Sonic Healthcare Limited (SHL)
Sonic Healthcare Limited (SHL) Receives a Hold from Jarden
J.P. Morgan Sticks to Its Hold Rating for Sonic Healthcare Limited (SHL)